Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 711-717

  Li, Ning ^a   Zhao, Minglang ^a   Wang, Jinzhao ^a   Liu, Zhi ^a   Diaz, Luis A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE INHIBITOR; IMMUNOGLOBULIN G; PROTEIN BAX; PROTEIN BCL XL; APOPTOSIS REGULATORY PROTEIN; AUTOANTIBODY; CASPASE; ENZYME INHIBITOR;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOSOLIC FRACTION; DOWN REGULATION; ENZYME ACTIVATION; EPIDERMIS CELL; HUMAN; MOUSE; NICK END LABELING; NONHUMAN; PATHOGENESIS; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE MODEL; DNA FRAGMENTATION; DRUG ANTAGONISM; ENZYMOLOGY; EPIDERMIS; IMMUNOLOGY; NEWBORN; PATHOLOGY; PEMPHIGUS; PHYSIOLOGY; SKIN;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOANTIBODIES; CASPASES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; ENZYME INHIBITORS; EPIDERMIS; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PEMPHIGUS; SKIN;

EID: 59849099433     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.711     Document Type: Article

References (55)

1. Anhalt, G. J., and L. A. Diaz. 2001. Prospects for autoimmune disease: research advances in pemphigus. J. Am. Med. Assoc. 285: 652-654.
2. Stanley, J. R., and M. Amagai. 2006. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N. Engl. J. Med. 355: 1800-1810.
3. Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67: 869-877.
4. Stanley, J. R., L. Koulu, and C. Thivolet. 1984. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J. Clin. Invest. 74: 313-320.
5. Anhalt, G. J., R. S. Labib, J. J. Voorhees, T. F. Beals, and L. A. Diaz. 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306: 1189-1196.
6. Roscoe, J. T., L. Diaz, S. A. Sampaio, R. M. Castro, R. S. Labib, Y. Takahashi, H. Patel, and G. J. Anhalt. 1985. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J. Invest. Dermatol. 85: 538-541.
7. Amagai, M., T. Hashimoto, K. J. Green, N. Shimizu, and T. Nishikawa. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104: 895-901.
8. Ding, X., L. A. Diaz, J. A. Fairley, G. J. Giudice, and Z. Liu. 1999. The antidesmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J. Invest. Dermatol. 112: 739-743.
9. Nguyen, V., T. X. Lee, A. Ndoye, L. D. Shultz, M. R. Pittelkow, M. V. Dahl, P. J. Lynch, and S. A. Grando. 1998. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity: development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch. Dermatol. 134: 971-980.
10. Evangelista, F., D. A. Dasher, L. A. Diaz, P. S. Prisayanh, and N. Li. 2008. E-cadherin is an additional immunological target for pemphigus autoantibodies. J. Invest. Dermatol. 128: 1710-1718.
11. Diaz, L. A., and C. L. Marcelo. 1978. Pemphigoid and pemphigus antigens in cultured epidermal cells. Br. J. Dermatol. 98: 631-637.
12. Sharma, P., X. Mao, and A. S. Payne. 2007. Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J. Dermatol. Sci. 48: 1-14.
13. Waschke, J., P. Bruggeman, W. Baumgartner, D. Zillikens, and D. Drenckhahn. 2005. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J. Clin. Invest. 115: 3157-3165.
14. Heupel, W. M., D. Zillikens, D. Drenckhahn, and J. Waschke. 2008. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J. Immunol. 181: 1825-1834.
15. Patel, H. P., L. A. Diaz, G. J. Anhalt, R. S. Labib, and Y. Takahashi. 1984. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J. Invest. Dermatol. 83: 409-415.
16. Calkins, C. C., S. V. Setzer, J. M. Jennings, S. Summers, K. Tsunoda, M. Amagai, and A. P. Kowalczyk. 2006. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J. Biol. Chem. 281: 7623-7634.
17. Aoyama, Y., M. K. Owada, and Y. Kitajima. 1999. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur. J. Immunol. 29: 2233-2240.
18. Cirillo, N., F. Femiano, F. Gombos, and A. Lanza. 2006. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett. 580: 3276-3281.
19. Cirillo, N., F. Gombos, and A. Lanza. 2007. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to antidesmoglein 1 pemphigus autoimmunity. J. Cell. Physiol. 210: 411-416.
20. Yamamoto, Y., Y. Aoyama, E. Shu, K. Tsunoda, M. Amagai, and Y. Kitajima. 2007. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J. Biol. Chem. 282: 17866-17876.
21. Delva, E., J. M. Jennings, C. C. Calkins, M. D. Kottke, V. Faundez, and A. P. Kowalczyk. 2008. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J. Biol. Chem. 283: 18303-18313.
22. Berkowitz, P., P. Hu, S. Warren, Z. Liu, L. A. Diaz, and D. S. Rubenstein. 2006. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc. Natl. Acad. Sci. USA 103: 12855-12860.
23. Lanza, A., N. Cirillo, R. Rossiello, M. Rienzo, L. Cutillo, A. Casamassimi, F. de Nigris, C. Schiano, L. Rossiello, F. Femiano, et al. 2008. Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J. Biol. Chem. 283: 8736-8745.
24. Chernyavsky, A. I., J. Arredondo, Y. Kitajima, M. Sato-Nagai, and S. A. Grando. 2007. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J. Biol. Chem. 282: 13804-13812.
25. Williamson, L., N. A. Raess, R. Caldelari, A. Zakher, A. de Bruin, H. Posthaus, R. Bolli, T. Hunziker, M. M. Suter, and E. J. Muller. 2006. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J. 25: 3298-3309.
26. Waschke, J., V. Spindler, P. Bruggeman, D. Zillikens, G. Schmidt, and D. Drenckhahn. 2006. Inhibition of Rho A activity causes pemphigus skin blistering. J. Cell Biol. 175: 721-727.
27. Frusic-Zlotkin, M., D. Raichenberg, X. Wang, M. David, B. Michel, and Y. Milner. 2006. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis: possible involvement of the EGF receptor. Autoimmunity 39: 563-575.
28. Berkowitz, P., P. Hu, Z. Liu, L. A. Diaz, J. J. Enghild, M. P. Chua, and D. S. Rubenstein. 2005. Desmosome signaling: inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J. Biol. Chem. 280: 23778-23784.
29. Caldelari, R., A. de Bruin, D. Baumann, M. M. Suter, C. Bierkamp, V. Balmer, and E. Muller. 2001. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J. Cell Biol. 153: 823-834.
30. Seishima, M., Y. Iwasaki-Bessho, Y. Itoh, Y. Nozawa, M. Amagai, and Y. Kitajima. 1999. Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. Arch. Dermatol. Res. 291: 606-613.
31. Arredondo, J., A. I. Chernyavsky, A. Karaouni, and S. A. Grando. 2005. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus. Am. J. Pathol. 167: 1531-1544.
32. Baroni, A., E. Buommino, I. Paoletti, M. Orlando, E. Ruocco, and V. Ruocco. 2004. Pemphigus serum and captopril induce heat shock protein 70 and inducible nitric oxide synthase overexpression, triggering apoptosis in human keratinocytes. Br. J. Dermatol. 150: 1070-1080.
33. Gniadecki, R., G. B. Jemec, B. M. Thomsen, and M. Hansen. 1998. Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch. Dermatol. Res. 290: 528-532.
34. Puviani, M., A. Marconi, E. Cozzani, and C. Pincelli. 2003. Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J. Invest. Dermatol. 120: 164-167.
35. Wang, X., F. Bregegere, M. Frusic-Zlotkin, M. Feinmesser, B. Michel, and Y. Milner. 2004. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 9: 131-143.
36. Pelacho, B., C. Natal, A. Espana, I. Sanchez-Carpintero, M. J. Iraburu, and M. J. Lopez-Zabalza. 2004. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett. 566: 6-10.
37. Li, N., M. Zhao, J. Hilario-Vargas, P. Prisayanh, S. Warren, L. A. Diaz, D. C. Roopenian, and Z. Liu. 2005. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J. Clin. Invest. 115: 3440-3450.
38. Zuccolotto, I., A. M. Roselino, L. N. Ramalho, and S. Zucoloto. 2003. Apoptosis and p63 expression in the pathogenesis of bullous lesions of endemic pemphigus foliaceus. Arch. Dermatol. Res. 295: 284-286.
39. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326.
40. Sahara, S., M. Aoto, Y. Eguchi, N. Imamoto, Y. Yoneda, and Y. Tsujimoto. 1999. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401: 168-173.
41. Frusic-Zlotkin, M., R. Pergamentz, B. Michel, M. David, D. Mimouni, F. Bregegere, and Y. Milner. 2005. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann. NY Acad. Sci. 1050: 371-379.
42. Schotte, P., W. Declercq, S. Van Huffel, P. Vandenabeele, and R. Beyaert. 1999. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442: 117-121.
43. Rozman-Pungercar, J., N. Kopitar-Jerala, M. Bogyo, D. Turk, O. Vasiljeva, I. Stefe, P. Vandenabeele, D. Bromme, V. Puizdar, M. Fonovic, M. Trstenjak-Prebanda, et al. 2003. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 10: 881-888.
44. Shimizu, H., Y. Banno, N. Sumi, T. Naganawa, Y. Kitajima, and Y. Nozawa. 1999. Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J. Invest. Dermatol. 112: 769-774.
45. Schwerk, C., and K. Schulze-Osthoff. 2003. Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem. Pharmacol. 66: 1453-1458.
46. Fischer, U., R. U. Janicke, and K. Schulze-Osthoff. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10: 76-100.
47. Dusek, R. L., S. Getsios, F. Chen, J. K. Park, E. V. Amargo, V. L. Cryns, and K. J. Green. 2006. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J. Biol. Chem. 281: 3614-3624.
48. Lanza, A., and N. Cirillo. 2007. Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus. Br. J. Dermatol. 156: 400-402.
49. Aho, S. 2004. Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action of different caspases. Exp. Dermatol. 13: 700-707.
50. Kalinin, A. E., M. Aho, J. Uitto, and S. Aho. 2005. Breaking the connection: caspase 6 disconnects intermediate filament-binding domain of periplakin from its actin-binding N-terminal region. J. Invest. Dermatol. 124: 46-55.
51. Weiske, J., T. Schoneberg, W. Schroder, M. Hatzfeld, R. Tauber, and O. Huber. 2001. The fate of desmosomal proteins in apoptotic cells. J. Biol. Chem. 276: 41175-41181.
52. Weedon, D., J. Searle, and J. F. Kerr. 1979. Apoptosis: its nature and implications for dermatopathology. Am. J. Dermatopathol. 1: 133-144.
53. Trautmann, A., M. Akdis, D. Kleemann, F. Altznauer, H. U. Simon, T. Graeve, M. Noll, E. B. Brocker, K. Blaser, and C. A. Akdis. 2000. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106: 25-35.
54. Viard, I., P. Wehrli, R. Bullani, P. Schneider, N. Holler, D. Salomon, T. Hunziker, J. H. Saurat, J. Tschopp, and L. E. French. 1998. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282: 490-493.
55. Paul, C., P. Wolkenstein, H. Adle, J. Wechsler, H. J. Garchon, J. Revuz, and J. C. Roujeau. 1996. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br. J. Dermatol. 134: 710-714.